Prospects for development and potential impact of a vaccine against congenital cytomegalovirus (CMV) infection.
Division of Pediatric Infectious Diseases, Department of Pediatrics, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA. schleiss@umn.edu
Mark R
MR
Schleiss
D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000151:congenital / Q000517:prevention & control*; D022482:Cytomegalovirus Vaccines; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D011247:Pregnancy; D019444:Vaccines, DNA; D014771:Virion / Q000648:ultrastructure
D022482:Cytomegalovirus Vaccines; D019444:Vaccines, DNA